Clinical Report: 10 Growing US Metro Areas to Consider for Private Practice
Background
Understanding the growth trends in metropolitan areas is crucial for healthcare professionals considering private practice. The US Census Bureau's estimates indicate that these regions are growing in population and enhancing their healthcare infrastructure.
Data Highlights
Metro Area
Population Growth
Healthcare Projects
Austin–Round Rock–San Marcos, TX
53,796 (2.1%)
$180 million expansion at St. David’s South Austin Medical Center
Boise City, ID
18,854 (2.2%)
Construction of a nine-story hospital tower by St. Luke’s
Charlotte–Concord–Gastonia, NC-SC
54,122 (1.9%)
12-story advanced care facility at Carolinas Medical Center
Dallas–Fort Worth–Arlington, TX
123,557
Frisco Station Medical Office Building
Greenville–Anderson–Greer, SC
14,474
$32 million ambulatory surgery center by Prisma Health
Nashville–Davidson–Murfreesboro–Franklin, TN
34,658 (1.6%)
Jim Ayers Tower at Vanderbilt University Medical Center
Orlando–Kissimmee–Sanford, FL
37,690 (1.3%)
14-story patient and surgical tower by AdventHealth
Phoenix–Mesa–Chandler, AZ
59,065
Scottsdale medical campus by Banner Health
Raleigh–Cary, NC
36,793 (2.4%)
230-acre children’s health campus by Duke Health and UNC Health
Tampa–St. Petersburg–Clearwater, FL
13,538 (0.4%)
BayCare expansion projects
Key Findings
All ten metropolitan areas experienced population growth between July 2024 and July 2025.
Austin–Round Rock–San Marcos had the highest numeric gain with 53,796 residents.
Dallas–Fort Worth–Arlington recorded the second-largest numeric gain with 123,557 residents.
Orlando–Kissimmee–Sanford's AdventHealth expansion is noted as a significant health care investment in Central Florida.
Raleigh–Cary is planning a children's health campus.
Clinical Implications
The growth in these metropolitan areas suggests an increasing demand for healthcare services, which may create opportunities for new practices. Healthcare professionals should consider these regions for potential practice locations, especially given the ongoing investments in healthcare infrastructure.
Nearly 40% of patients initiated thyroid hormone therapy within 2 years of hemithyroidectomy, with higher preoperative thyroid‐stimulating hormone levels and thyroid cancer identifying those at greatest risk.
